Back to all people

Amy Xia

Amgen

1 appearance in the program

Sessions & presentations

PS21: FDA's CDER and CBER PDUFA VII Guidance on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Development and Implementation

Presentation: Panel Discussion

Parallel · Thu, Sep 17 , 4:15 PM

Panelist

↑